Morgan R. Brown's Insider Trades & SAST Disclosures
Morgan R. Brown's most recent trade in Clene Inc was a trade of 20,000 Stock Options (Right to buy) done . Disclosure was reported to the exchange on Feb. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Morgan R. Brown.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Clene Inc | Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 20,000 | 20,000 | - | - | Stock Options (Right to buy) | |
| Clene Inc | Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2024 | 10,000 | 10,000 | - | - | Stock Options (Right to buy) | |
| Clene Inc | Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 600,000 | 600,000 | - | - | Stock Options (Right to buy) | |
| Clene Inc | Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 400,000 | 400,000 | - | - | Stock Options (Right to buy) | |
| Clene Inc | Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2023 | 400,000 | 400,000 | - | - | Stock Options (Right to buy) | |
| Clene Inc | Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 125,000 | 125,000 | - | - | Stock Options (Right to buy) | |
| Clene Inc | Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2022 | 300,000 | 300,000 | - | - | Stock Options (Right to buy) | |
| Clene Inc | Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 250,000 | 250,000 | - | - | Stock Options (Right to buy) | |
| Lipocine Inc | Morgan R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 176,000 | 176,000 | - | - | Stock Option (Right to Buy) | |
| Lipocine Inc | Morgan R. Brown | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 160,000 | 160,000 | - | - | Stock Options (Right to Buy) | |
| Lipocine Inc | Morgan R. Brown | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 28,125 | 202,941 (0%) | 0% | 0 | Common Stock | |
| Lipocine Inc | Morgan R. Brown | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 28,125 | 28,125 | - | - | Restricted Stock Unit | |
| Lipocine Inc | Morgan R. Brown | EVP and CFO | Sale of securities on an exchange or to another person at price $ 1.35 per share. | 15 Dec 2020 | 8,437 | 194,504 (0%) | 0% | 1.4 | 11,390 | Common Stock |
| Lipocine Inc | Morgan R. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2020 | 70,754 | 174,816 (0%) | 0% | 0 | Common Stock | |
| Lipocine Inc | Morgan R. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2020 | 70,754 | 70,754 | - | - | Restricted Stock Unit | |
| Lipocine Inc | Morgan R. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2020 | 57,500 | 57,500 | - | - | Restricted Stock Unit | |
| Lipocine Inc | Morgan R. Brown | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2020 | 57,500 | 121,312 (0%) | 0% | 0 | Common Stock | |
| Lipocine Inc | Morgan R. Brown | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.57 per share. | 04 Dec 2020 | 17,250 | 104,062 (0%) | 0% | 1.6 | 27,024 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges